Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$468 Mln
Revenue (TTM)
$3 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.6 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
2.5
Industry P/E
--
EV/EBITDA
-0.4
Div. Yield
0 %
Debt to Equity
0
Book Value
$1.4
EPS
$-0.8
Face value
--
Shares outstanding
153,021,263
CFO
$-223.57 Mln
EBITDA
$-289.22 Mln
Net Profit
$-337.80 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Absci Corp (ABSI)
| -12.3 | 11.7 | -12.3 | 27.5 | 20.5 | -- | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Absci Corp (ABSI)
| 33.2 | -37.4 | 100.0 | -74.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Absci Corp (ABSI)
|
3.1 | 468.3 | 2.8 | -115.2 | -4,454.2 | -62.5 | -- | 2.5 |
| 61.0 | 8,546.2 | 1,091.0 | 202.3 | 31.6 | 31.3 | 38.1 | 15.0 | |
| 66.7 | 8,218.7 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.5 | |
| 43.9 | 11,247.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.9 | 5.0 | |
| 93.8 | 12,307.7 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 60.9 | |
| 64.5 | 7,640.4 | 1,396.6 | 316.9 | 59.8 | 153.6 | 25.2 | 156.5 | |
| 546.9 | 11,592.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 | |
| 498.3 | 14,143.5 | 2,530.2 | 451.1 | 21.3 | 70.2 | 32.7 | 30.2 | |
| 105.4 | 8,288.6 | 0.0 | -425.4 | -- | -36.7 | -- | 6.7 | |
| 310.4 | 8,644.3 | 0.0 | -303.3 | -- | -45.8 | -- | 10.1 |
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory... bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington. Read more
Founder, CEO, President & Director
Mr. Sean McClain
Founder, CEO, President & Director
Mr. Sean McClain
Headquarters
Vancouver, WA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Absci Corp (ABSI) is $3.06 (NASDAQ) as of 02-Apr-2026 19:58 EDT. Absci Corp (ABSI) has given a return of 20.47% in the last 3 years.
Since, TTM earnings of Absci Corp (ABSI) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-4.15
|
2.52
|
|
2024
|
-2.80
|
1.61
|
|
2023
|
-3.49
|
2.19
|
|
2022
|
-1.82
|
0.70
|
|
2021
|
-4.06
|
1.12
|
The 52-week high and low of Absci Corp (ABSI) are Rs 5.23 and Rs 2.01 as of 05-Apr-2026.
Absci Corp (ABSI) has a market capitalisation of $ 468 Mln as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Absci Corp (ABSI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.09
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.